Table 1 Characteristics of the 45 AML patients at diagnosis
All patients | FISH + CD34 + CD38- | FISH + CD34 + CD38- | P value | |
|---|---|---|---|---|
N = 45 | <1% | ≥1% | ||
N = 20 | N = 25 | |||
Gender | ||||
Male(%) | 25(55.6) | 10(50) | 15(60) | 0.557 |
Female(%) | 20(44.4) | 10(50) | 10(40) | |
Age, Median(range) | 42(14–71) | 36(19–71) | 45(14–66) | 0.5600 |
WBC, Median(range) | 14.5(0.63-143) | 12.4(0.63-125.24) | 14.9(1.7-143) | 0.9091 |
PLT, Median(range) | 42(4–191) | 28(4–191) | 48(16–157) | 0.198 |
BM blast% | 58(18–96) | 52.5(20–94.5) | 62(18–96) | 0.265 |
FAB subtype | 0.694 | |||
M1 | 5 | 2 | 3 | |
M2 | 18 | 10 | 8 | |
M4 | 12 | 5 | 7 | |
M5 | 9 | 3 | 6 | |
M6 | 1 | 0 | 1 | |
Cytogenetics risk | 0.894 | |||
Favorable | 24 | 10 | 14 | |
Intermediate | 12 | 6 | 6 | |
Poor | 9 | 4 | 5 | |
FLT3 mutations (%) | 5(11.1) | 2(10) | 3(12) | 1 |
Allo-HSCT(%) | 14(31.1) | 6(30) | 8(32) | 1 |